NASDAQ: NUTX
Nutex Health Inc Stock

$159.95-1.91 (-1.18%)
Updated May 23, 2025
NUTX Price
$159.95
Fair Value Price
$286.52
Market Cap
$890.23M
52 Week Low
$4.16
52 Week High
$184.28
P/E
12.28x
P/B
4.52x
P/S
0.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$624.28M
Earnings
$67.18M
Gross Margin
48.8%
Operating Margin
19.45%
Profit Margin
10.8%
Debt to Equity
2.47
Operating Cash Flow
$71M
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NUTX Overview

Nutex Health Inc. operates micro-hospitals, specialty hospitals, and hospital outpatient departments. It also provides a cloud-based technology platform that aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers. Nutex Health was founded in 2011 and is headquartered in Houston, TX.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NUTX's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
A
NUTX
Ranked
#8 of 42

Top Ranked Stocks in Industry

View Top Health Information Service Stocks

Be the first to know about important NUTX news, forecast changes, insider trades & much more!

NUTX News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NUTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NUTX ($159.95) is undervalued by 44.17% relative to our estimate of its Fair Value price of $286.52 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NUTX ($159.95) is significantly undervalued by 44.17% relative to our estimate of its Fair Value price of $286.52 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NUTX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NUTX due diligence checks available for Premium users.

Valuation

NUTX fair value

Fair Value of NUTX stock based on Discounted Cash Flow (DCF)

Price
$159.95
Fair Value
$286.52
Undervalued by
44.17%
NUTX ($159.95) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NUTX ($159.95) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NUTX was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NUTX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
12.28x
Industry
43.88x
Market
21.18x
NUTX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NUTX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NUTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.52x
Industry
3.54x
NUTX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NUTX's financial health

Profit margin

Revenue
$211.8M
Net Income
$14.6M
Profit Margin
6.9%
NUTX's Earnings (EBIT) of $121.41M... subscribe to Premium to read more.
Interest Coverage Financials
NUTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$761.9M
Liabilities
$487.0M
Debt to equity
2.47
NUTX's short-term assets ($401.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NUTX's short-term assets ($401.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NUTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$51.0M
Investing
-$64.0k
Financing
-$6.8M
NUTX's operating cash flow ($71.07M)... subscribe to Premium to read more.
Debt Coverage Financials

NUTX vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NUTXB$890.23M-1.18%12.28x4.52x
EVHF$846.45M-2.04%-5.91x0.90x
HSTMC$834.87M-1.69%43.41x2.30x
TXGB$1.01B-4.33%-6.24x1.42x
WEAVC$720.99M-1.54%-22.83x10.51x

Nutex Health Stock FAQ

What is Nutex Health's quote symbol?

(NASDAQ: NUTX) Nutex Health trades on the NASDAQ under the ticker symbol NUTX. Nutex Health stock quotes can also be displayed as NASDAQ: NUTX.

If you're new to stock investing, here's how to buy Nutex Health stock.

What is the 52 week high and low for Nutex Health (NASDAQ: NUTX)?

(NASDAQ: NUTX) Nutex Health's 52-week high was $184.28, and its 52-week low was $4.16. It is currently -13.2% from its 52-week high and 3,744.95% from its 52-week low.

How much is Nutex Health stock worth today?

(NASDAQ: NUTX) Nutex Health currently has 5,565,679 outstanding shares. With Nutex Health stock trading at $159.95 per share, the total value of Nutex Health stock (market capitalization) is $890.23M.

Nutex Health stock was originally listed at a price of $4,500.00 in Apr 18, 2018. If you had invested in Nutex Health stock at $4,500.00, your return over the last 7 years would have been -96.45%, for an annualized return of -37.92% (not including any dividends or dividend reinvestments).

How much is Nutex Health's stock price per share?

(NASDAQ: NUTX) Nutex Health stock price per share is $159.95 today (as of May 23, 2025).

What is Nutex Health's Market Cap?

(NASDAQ: NUTX) Nutex Health's market cap is $890.23M, as of May 25, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nutex Health's market cap is calculated by multiplying NUTX's current stock price of $159.95 by NUTX's total outstanding shares of 5,565,679.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.